Compare · HIND vs MDLN
HIND vs MDLN
Side-by-side comparison of Vyome Holdings Inc. (HIND) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIND and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $42.85B, about 2963.5x HIND ($14.5M).
- Over the past year, HIND is down 72.2% and MDLN is down 20.0% - MDLN leads by 52.2 points.
- HIND has been more active in the news (7 items in the past 4 weeks vs 1 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 1 for HIND).
PerformanceHIND-49.14%MDLN-19.98%
2025-12-16+0.00%2026-09-11
- Company
- Vyome Holdings Inc.
- Medline Inc.
- Price
- $2.08+0.97%
- $32.61+0.22%
- Market cap
- $14.5M
- $42.85B
- 1M return
- -6.73%
- -8.37%
- 1Y return
- -72.19%
- -19.98%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2025
- News (4w)
- 7
- 1
- Recent ratings
- 1
- 25
Latest HIND
- Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer
- SEC Form 4 filed by Vyome Holdings Inc.
- Chardan Capital Markets initiated coverage on Vyome Holdings with a new price target
- SEC Form 3 filed by new insider Leonard Jerry
- Vyome Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Vyome Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet
- SEC Form 10-Q filed by Vyome Holdings Inc.
- Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio
- Vyome Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest MDLN
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.